These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2690116)

  • 21. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
    Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
    Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatoglyphic patterns in senile dementia of Alzheimer's type.
    Okra Podrabinek N; Roudier M; Lamour Y; de Grouchy J
    Ann Genet; 1988; 31(2):91-6. PubMed ID: 2969696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems.
    Bucht G; Adolfsson R; Winblad B
    J Am Geriatr Soc; 1984 Jul; 32(7):491-8. PubMed ID: 6203954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment issues in clinical trials of tetrahydroaminoacridine and studies to alter decline in Alzheimer disease.
    Thal LJ
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S37-9. PubMed ID: 1781972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological classification of dementias by multivariate data analysis.
    Alafuzoff I; Iqbal K; Friden H; Adolfsson R; Winblad B
    Prog Clin Biol Res; 1989; 317():295-301. PubMed ID: 2602421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and senile dementia of Alzheimer type. A comparative study.
    Sulkava R
    Acta Neurol Scand; 1982 Jun; 65(6):636-50. PubMed ID: 7113668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle.
    Wisniewski HM; Merz PA; Iqbal K
    J Neuropathol Exp Neurol; 1984 Nov; 43(6):643-56. PubMed ID: 6542129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified Hortega-Globus stain is superior to Bielschowsky and Bodian stains for demonstrating neuritic plaques.
    Bolle L; Maurer B; Janzer RC
    Biotech Histochem; 1992 Mar; 67(2):82-7. PubMed ID: 1376153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study.
    Alafuzoff I; Adolfsson R; Grundke-Iqbal I; Winblad B
    Acta Neuropathol; 1987; 73(2):160-6. PubMed ID: 3300132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Three patients with insulin-treated diabetes and senile dementia of Alzheimer's type].
    Tomono S; Kawazu S; Utsugi T; Ohno T; Katto N; Ohyama Y; Uchiyama T; Nagai R
    Nihon Ronen Igakkai Zasshi; 1998 Mar; 35(3):25-8. PubMed ID: 9597883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinicopathological study of senile dementia of Alzheimer's type (SDAT) and white matter lesions of Binswanger's type].
    Meguro K; Matsushita M; Yoshida R; Otomo E; Yamaguchi S; Nakagawa T; Sasaki H
    Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):226-31. PubMed ID: 8207874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Senile dementia, Alzheimer-type (SDAT). A review of present knowledge.
    Fisk AA
    Wis Med J; 1979 Nov; 78(11):29-33. PubMed ID: 516784
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid.
    Wang GP; Iqbal K; Bucht G; Winblad B; Wisniewski HM; Grundke-Iqbal I
    Acta Neuropathol; 1991; 82(1):6-12. PubMed ID: 1659107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of dementias using partial least squares discriminant analysis.
    Gottfries J; Blennow K; Wallin A; Gottfries CG
    Dementia; 1995; 6(2):83-8. PubMed ID: 7606284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
    Reinikainen KJ; Riekkinen PJ; Paljärvi L; Soininen H; Helkala EL; Jolkkonen J; Laakso M
    Neurochem Res; 1988 Feb; 13(2):135-46. PubMed ID: 3362291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative MR imaging in Alzheimer disease.
    Ramani A; Jensen JH; Helpern JA
    Radiology; 2006 Oct; 241(1):26-44. PubMed ID: 16990669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Wettstein A; Spiegel R
    Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.